Why the study?
Patients with hypertrophic cardiomyopathy exhibit various physical findings, but their clinical significance has not been systematically evaluated.
Does the presence of specific physical examination findings (visible Jug-a, audible S4, abnormal apex beat) aid in the diagnosis and risk stratification of patients with hypertrophic cardiomyopathy?
Does the presence of specific physical examination findings (visible Jug-a, audible S4, abnormal apex beat) aid in the diagnosis and risk stratification of patients with hypertrophic cardiomyopathy?
Answers are grounded in this paper and cite their sources.
Physical examination findings, particularly the absence of an audible S4, provide valuable diagnostic and prognostic information for risk stratification in patients with hypertrophic cardiomyopathy.
BACKGROUND: Patients with hypertrophic cardiomyopathy (HCM) show various physical findings, but their clinical significance has not been systematically evaluated. METHODS AND RESULTS: This study evaluated 105 consecutive patients with HCM who had undergone phonocardiography and external pulse recording. Physical examinations included a visible jugular a-wave (Jug-a), audible 4th sound (S4), and double or sustained apex beat. The primary outcome was a composite of all-cause death and hospitalization for cardiovascular disease. A total of 104 non-HCM subjects served as controls. The prevalence of visible Jug-a in the seated or supine position, audible S4, and a sustained or double apex beat in patients with HCM were 10%, 71%, 70%, 42%, and 27%, respectively, all of which were significantly higher than in the controls (0%, 20%, 11%, 17%, and 2%; P<0.001 for all comparisons). The combination of visible Jug-a in the supine position and audible S4 yielded a specificity of 94% and sensitivity of 57%. During a follow-up period of 6.6 years, 6 patients died and 10 were hospitalized. The absence of audible S4 was a predictor of cardiovascular events (hazard ratio, 3.91; 95% confidence interval, 1.41 to 10.8; P=0.005). CONCLUSIONS: Detection of these findings has clinical importance in the diagnosis and risk stratification of HCM prior to the use of advanced imaging techniques.
No takes yet. Share an insight, caveat, or question.
Kawasaki et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: